Porphyromonas gingivalis antigens and interleukin-6 stimulate the production of monocyte chemoattractant protein-1 via the upregulation of early growth response-1 transcription in human coronary artery endothelial cells

Journal of Vascular Research

Volumn 47, Issue 4, 2010, Pages 346-354

  Maekawa, Tomoki ^a   Takahashi, Naoki ^a   Honda, Tomoyuki ^a   Yonezawa, Daisuke ^a   Miyashita, Hirotaka ^a   Okui, Takafumi ^a   Tabeta, Koichi ^a   Yamazaki, Kazuhisa ^a  

^a NIIGATA UNIVERSITY   (Japan)

Author keywords

Atherosclerosis; Egr 1; Endothelial cell; MCP 1; Periodontitis

Indexed keywords

BACTERIAL ANTIGEN; EARLY GROWTH RESPONSE FACTOR 1; INTERLEUKIN 6; INTERLEUKIN 6 RECEPTOR; MONOCYTE CHEMOTACTIC PROTEIN 1; SMALL INTERFERING RNA;

ARTICLE; CORONARY ARTERY; ENDOTHELIUM CELL; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; NONHUMAN; PORPHYROMONAS GINGIVALIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION;

ANTIGENS, BACTERIAL; CELLS, CULTURED; CHEMOKINE CCL2; CORONARY VESSELS; EARLY GROWTH RESPONSE PROTEIN 1; ENDOTHELIAL CELLS; HUMANS; INTERLEUKIN-6; PORPHYROMONAS GINGIVALIS; RECEPTORS, INTERLEUKIN-6; RECOMBINANT PROTEINS; RNA INTERFERENCE; RNA, MESSENGER; UP-REGULATION;

EID: 72049128927     PISSN: 10181172     EISSN: None     Source Type: Journal    
DOI: 10.1159/000265568     Document Type: Article

References (38)

1. Ross R: Atherosclerosis-an inflammatory disease. N Engl J Med 1999; 340:115-126.
2. Shah PK: Plaque disruption and thrombosis. Potential role of inflammation and infection. Cardiol Clin 1999; 17:271-281.
3. Kuvin JT, Kimmelstiel CD: Infectious causes of atherosclerosis. Am Heart J 1999; 137:216-226.
4. Libby P, Egan D, Skarlatos S: Roles of infectious agents in atherosclerosis and resteno-sis: an assessment of the evidence and need for future research. Circulation 1997; 96: 4095-4103.
5. Bahekar AA, Singh S, Saha S, Molnar J, Aro-ra R: The prevalence and incidence of coronary heart disease is significantly increased in periodontitis: a meta-analysis. Am Heart J 2007; 154: 830-837.
6. Schenkein HA, Barbour SE, Berry CR, Kipps B, Tew JG: Invasion of human vascular en-dothelial cells by Actinobacillus actinomy-cetemcomitans via the receptor for platelet-activating factor. Infect Immun 2000; 68: 5416-5419.
7. Spahr A, Klein E, Khuseyinova N, Boeckh C, Muche R, Kunze M, Rothenbacher D, Pezeshki G, Hoffmeister A, Koenig W: Peri-odontal infections and coronary heart disease: role of periodontal bacteria and importance of total pathogen burden in the coronary event and periodontal disease (corodont) study. Arch Intern Med 2006; 166: 554-559.
8. Kuramitsu HK, Kang IC, Qi M: Interactions of porphyromonas gingivalis with host cells: implications for cardiovascular diseases. J Periodontol 2003; 74:85-89.
9. Yamazaki K, Honda T, Domon H, Okui T, Kajita K, Amanuma R, Kudoh C, Takashiba S, Kokeguchi S, Nishimura F, Kodama M, Aizawa Y, Oda H: Relationship of periodon-tal infection to serum antibody levels to peri-odontopathic bacteria and inflammatory markers in periodontitis patients with coronary heart disease. Clin Exp Immunol 2007; 149: 445-452.
10. Ioannidou E, Malekzadeh T, Dongari-Bagt-zoglou A: Effect of periodontal treatment on serum c-reactive protein levels: a systematic review and meta-analysis. J Periodontol 2006; 77: 1635-1642.
11. Nakajima T, Honda T, Domon H, Okui T, Kajita K, Ito H, Takahashi N, Maekawa T, Ta-beta K, Yamazaki K: Periodontitis associated up-regulation of systemic inf lammatory mediator level may increase the risk of coronary heart disease. J Periodont Res 2009, E-pub ahead of print.
12. Blaschke F, Bruemmer D, Law RE: Egr-1 is a major vascular pathogenic transcription factor in atherosclerosis and restenosis. Rev En-docr Metab Disord 2004; 5: 249-25 4.
13. Khachigian LM: Early growth response-1 in cardiovascular pathobiology. Circ Res 2006; 98:186-191.
14. Epstein SE, Zhou YF, Zhu J: Infection and atherosclerosis: Emerging mechanistic paradigms. Circulation 1999; 100:e20-e28.
15. Fahmy RG, Dass CR, Sun LQ, Chesterman CN, Khachigian LM: Transcription factor Egr-1 supports FGF-dependent angiogenesis during neovascularization and tumor growth. Nat Med 2003; 9:1026-1032.
16. Fahmy RG, Khachigian LM: Locked nucleic acid modified DNA enzymes targeting early growth response-1 inhibit human vascular smooth muscle cell growth. Nucleic Acids Res 2004; 32:2281-2285.
17. Lalla E, Lamster IB, Hofmann MA, Bucciarelli L, Jerud AP, Tucker S, Lu Y, Papapanou PN, Schmidt AM: Oral infection with a peri-odontal pathogen accelerates early atherosclerosis in apolipoprotein e-null mice. Arte-rioscler Thromb Vasc Biol 2003; 23: 1405-1411.
18. Hof fma n n E, Ashour i J, Wolter S, Doer r ie A, Dittrich-Breiholz O, Schneider H, Wagner EF, Troppmair J, Mackman N, Kracht M: Transcriptional regulation of EGR-1 by the interleukin-1-JNK-MKK7-c-Jun pathway. J Biol Chem 2008; 283:12120-12128.
19. Boring L, Gosling J, Cleary M, Charo IF: Decreased lesion formation in CCR2-/-mice reveals a role for chemokines in the initiation of atherosclerosis. Nature 1998; 394:894-897.
20. Gu L, Okada Y, Clinton SK, Gerard C, Suk-hova GK, Libby P, Rollins BJ: Absence of monocyte chemoattractant protein-1 reduces atherosclerosis in low density lipoprotein receptor-deficient mice. Mol Cell 1998; 2: 275-281.
21. Yan SF, Fujita T, Lu J, Okada K, Shan Zou Y, Mackman N, Pinsky DJ, Stern DM: Egr-1, a master switch coordinating upregulation of divergent gene families underlying ischemic stress. Nat Med 2000; 6: 1355-1361.
22. Harja E, Bucciarelli LG, Lu Y, Stern DM, Zou YS, Schmidt AM, Yan SF: Early growth response-1 promotes atherogenesis: mice deficient in early growth response-1 and apolipoprotein E display decreased atherosclerosis and vascular inflammation. Circ Res 2004; 94:333-339.
23. McCaffrey TA, Fu C, Du B, Eksinar S, Kent KC, Bush H, Jr., Kreiger K, Rosengart T, Cy-bulsky MI, Silverman ES, Collins T: High-level expression of Egr-1 and Egr-1-inducible genes in mouse and human atherosclerosis. J Clin Invest 20 00; 105: 653-662.
24. Morawietz H, Ma YH, Vives F, Wilson E, Sukhatme VP, Holtz J, Ives HE: Rapid induction and translocation of Egr-1 in response to mechanical strain in vascular smooth muscle cells. Circ Res 1999; 84: 678-687.
25. Rupp J, Hellwig-Burgel T, Wobbe V, Seitzer U, Brandt E, Maass M: Chlamydia pneu-moniae infection promotes a proliferative phenotype in the vasculature through Egr-1 activation in vitro and in vivo. Proc Natl Acad Sci USA 2005; 102:3447-3452.
26. Domon H, Honda T, Oda T, Yoshie H, Yamazaki K: Early and preferential induction of IL-1 receptor-associated kinase-M in THP-1 cells by LPS derived from porphy-romonas gingivalis. J Leukoc Biol 20 08; 83: 672-679.
27. Roth GA, Moser B, Roth-Walter F, Giacona MB, Harja E, Papapanou PN, Schmidt AM, Lalla E: Infection with a periodontal pathogen increases mononuclear cell adhesion to human aortic endothelial cells. Atherosclerosis 2007; 190:271-281. (Pubitemid 46074042)
28. Padilla C, Lobos O, Hubert E, González C, Matus S, Pereira M, Hasbun S, Descouvieres C: Periodontal pathogens in atheromatous plaques isolated from patients with chronic periodontitis. J Periodontal Res 2006; 41: 350-353.
29. Zaremba M, Górska R, Suwa lsk i P, Kowalski J: Evaluation of the incidence of periodonti-tis-associated bacteria in the atherosclerotic plaque of coronary blood vessels. J Periodon-tol 2007; 78: 322-327.
30. Yamazaki K, Ohsawa Y, Itoh H, Ueki K, Ta-beta K, Oda T, Nakajima T, Yoshie H, Saito S, Oguma F, Kodama M, Aizawa Y, Seymour GJ: T-cell clonality to Porphyromonas gin-givalis and human heat shock protein 60s in patients with atherosclerosis and perio-dontitis. Oral Microbiol Immunol 2004; 19: 160-167.
31. Cairo F, Gaeta C, Dorigo W, Oggioni MR, Pratesi C, Pini Prato GP, Pozzi G: Periodon-tal pathogens in atheromatous plaques. A controlled clinical and laboratory trial. J Periodontal Res 2004; 39:442-446.
32. Aimetti M, Romano F, Nessi F: Microbiolog-ic analysis of periodontal pockets and carotid atheromatous plaques in advanced chronic periodontitis patients. J Periodontol 2007; 78: 1718-172 3.
33. D'Aiuto F, Parkar M, Andreou G, Suvan J, Brett PM, Ready D, Tonetti MS: Periodonti-tis and systemic inf lammation: control of the local infection is associated with a reduction in serum inflammatory markers. J Dent Res 2004; 83: 156-16 0.
34. Pussinen PJ, Tuomisto K, Jousilahti P, Havu-linna AS, Sundvall J, Salomaa V: Endotox-emia, immune response to periodontal pathogens, and systemic inf lammation associate with incident cardiovascular disease events. Arterioscler Thromb Vasc Biol 2007; 27: 1433-1439.
35. Ridker PM, Rifai N, Stampfer MJ, Henne-kens CH: Plasma concentration of interleu-kin-6 and the risk of future myocardial infarction among apparently healthy men. Circulation 2000; 101:1767-1772.
36. Ridker PM, Hennekens CH, Buring JE, Rifai N: C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 2000; 342: 836-843. (Pubitemid 30165206)
37. Romano M, Sironi M, Toniatti C, Polenta-rutti N, Fruscella P, Ghezzi P, Faggioni R, Luini W, van Hinsbergh V, Sozzani S, Bus-solino F, Poli V, Ciliberto G, Mantovani A: Role of IL-6 and its soluble receptor in induction of chemokines and leukocyte recruitment. Immunity 1997; 6:315-325.
38. Rott D, Zhu J, Zhou YF, Burnett MS, Zalles-Ganley A, Epstein SE: IL-6 is produced by splenocytes derived from CMV-infected mice in response to CMV antigens, and induces MCP-1 production by endothelial cells: a new mechanistic paradigm for infection-induced atherogenesis. Atherosclerosis 2003; 170:223-228.